510(K) Summary K102148



Similar documents
510(k) Summary GlobalMedia Group, LIC. MAY CONiM

AW Server 510 (k) Summary of Safety and Effectiveness

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

0 EC V-,) 133 Lj9a

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

University of Texas Medical School at Houston. April 14, 2015

MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

February 5, Dear Kristin Pabst,

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

January 12, Dear Amy Yang:

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

GE Healthcare MAR

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

Q(K SVJM~jPagelIof 3

April 3, Dear Autumn Liu,

(k) SUMMARY DEC

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

July 24, Dear Ms. Rhodes:

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

(k)Suminary k

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

510(k) Summary. Dentsply Implants. April 30, 2013

BMR ~131o-lvleccai Kesearcn Ltd.

FEB Mr. Gordon J. Peters Director Regulatory Compliance DocuSys, Incorporated 820 S. University Boulevard, Suite 3-H Mobile, Alabama 36609

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

Section 5-510(k) Summary. This document is provided in the following pages. DEC

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

I~r it NOV SIE T AENCORE Tongue Suspension System OCE L_ August 3, (k) Summary. Appendix 3:

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

March 3, Dear Ms. Alice Gong,

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

May 5, Dear Mr. Courtney:

Ultimate Concepts Inc.

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

March 20, Dear Mr. Chen:

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

510(K) SUMMARY. 510(k) Number KOS'00-r

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

September 17, Keeler Instruments Inc. Mr. Eugene R. Van Arsdale Marketing Manager 459 Parkway Broomall, PA 19008

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

510(k) SUMMARY APR Date: 15 th December 2008

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

L~l t l V~! MAY ?

510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

Manufacturing Technology, Inc.

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

May 22, Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

51O(K) SUMMARY: Therapy family of devices.

Dental Morelli Ltda.

510(k) Summary (c)

W~c f-t. MAR 2 1 2fl09SC. 5 10(k) summary TRACTION MASTERS, INC. Traction Masters, Inc. AKA: Spinetronics, LLC 9737 NW 65 PL Parkland, Florida 33076

JN (k) Summary Device Identification: Device Description:

September 25, Dear Ms. McCoy:

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

DEC V,(9/azO (c 0 j

J UN (k) SUMMARY AS REQUIRED BY SECTION (C) Mrs. Mitsuko Yoneyama President. Submitted by:

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

IQ Corporation c/o Harold G. Haines, Ph.D. President SEP 1 f 2002 South Florida BioAssociates, Inc SW 127h Street Miami, Florida

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

Fresenius Medical Care

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

October 29, Dear Ms. Hartnett:

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

510(k) SUMMARY. OPTION-vyM Urinary Catheter

MAY Attachment (k) Summary 21 CER

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

Summary of Safety and Effectiveness

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

Supports screening, diagnostic, and multimodality workflows

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

510(k) Summary of Safety SE K1

510(k) Summary SUBMITTER'S NAME, ADDRESS, TELEPHONE NUMBER, CONTACT PERSON, AND DATE SUMMARY PREPARED:

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices

Medical Devices; Cardiovascular Devices; Classification of the Esophageal Thermal Regulation

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

Transcription:

510(K) Summary K102148 Moksha Digital Software PVT Limited #161 1, Janardhana Towers, 7th Cross, 19th Main, Sector 1, HSR Layout, Bangalore 560034, India AG1721 Phone:±+91 (80) 4110 1208AU 1720 Fax: +91 (80) 4110 1824 E-mail : sales~mokshadigitai.com Contact: Deepak Sharma, Managing Director Date prepared: August 12, 2010 1 Trade Name: CuriePACS Dicom PACS Software Common Name: PACS Software Classification Name: System, image processing, radiological 2. Regulation Description Picture archiving and communications system, product code LLZ, Regulation: 892.2050 Class of device: Class Il. 3. The legally marketed device to which we are claiming equivalence Voyager PACS System, Voyager Imaging, K062062. 4. Description of device: CuriePACS is a comprehensive solution for Dicom imaging needs. This scalable PACS solution provides electronic viewing, storage and communication in a secure environment. The device consists of: 1. Dicom Server (MD Athena) - For storage and connectivity with all the modalities and 2. Image Viewer (MD Vision) - To connect to the server and retrieve images based on search criteria and other workflow requirements. Image modalities supported: CR, CT, DX, MG, MR, NM, RF, SC, US, XA (x-ray), and ES. 5. Indications for use: CuriePACS (Dicom PACS Software) Software is a software device that receives digital images and data from various sources (Computed Radiography, Magnetic Resonance Imaging, Ultrasound, Endoscopy, Computed Tomography, Digital X-Ray Mammography, Nuclear Medicine Imaging, Secondary Capture, Radio Fluoroscopy, X-Ray or other Angiograms such as CT Angio). Images and data can he captured, stored, communicated, processed and displayed within the system and or across computer networks at distributed locations. Lossy compressed mammographic images and digitized film screen images must not be reviewed for primary image interpretation. Mamnmographic images may only be interpreted using an FDA cleared monitor that offers at least 5 Megapixel resolution and meets other technical specifications reviewed and accepted by FDA. 6. Technological characteristics: The software is installed on a network connected PACS server with the following minimum requirements: * Microsoft Windows XP Service Pack 2 or above * Microsoft Windows ) Vista Service Pack I or above *Microsoft.Net Framework 3.5 SP I *Microsoft Internet Explorer 7 or above *Intel Core 2 Duo Processor *320013 HDD

2GB RAM (Min) * Dedicated or Onboard Graphics card with minimum 1440 x 900 resolution and DVI output. * Gigabit Ethernet Adaptor * Display: The display used for diagnosis purposes should be FDA approved self calibrating medical grade monitor which is driven by a digital input (DVI output from graphics card). 7. Cornparison Table Characteristic Predicate Device CuriePACS (Dicom PACS Software) Voyager PACS System, Voyager (This submission) Imaging, K062062 Indications for Voyager PACS System is a software based dev CuriePACS (Dicom PACS Software) Software Use ice that receives digital images and data from is a software device that receives digital various sources (i.e. CT scanners, MR scanners, images and data from various sources ultrasound systems, RIF Units, (Computed Radiography, Magnetic Resonance computed & direct radiographic devices. Imaging, Ultrasound, Endoscopy, Computed secondary capture dev ices, scanners, imaging Tomography, Digital X-Ray Mammography, gateways, etc.). Images and data can be Nuclear Medicine Imaging, Secondary captured, stored, communicated, processed and Capture, Radio Fluoroscopy, X-Ray or other displayed within the system and or across Angiograms such as CT Angio). Images and computer networks at distributed locations, data can he captured, stored, communicated, Lossy compressed marmmographic images and processed and displayed within the system and digitized film screen images must niot be or across computer networks at distributed reviewed for primary image interpretation, locations. Lossy compressed mammographic Mammographic images may only be interpreted images and digitized film screen images must using an FDA approved monitor that offers at not be reviewed for primary image least 5 Mpixel resolution and meets other interpretation. Mammographic images may technical specifications reviewed and accepted only be interpreted using an FDA cleared by FDA. monitor that offers at least 5 Megapixel resolution and meets other technical speifcaion rviwed and accepted by FDA. Use, key feature Medical professionals, WEB based SAME Connection WEB and Ethernet SAME Multimodality Voyager PACS can receive with ease Connect all DICOM Modalities CR, Connectivity, any DICOM compliant image, CT, DX, MG, MR, NM, RF, SC, DICOM irrespective of the source US, XA (x-ray), and ES. com patibility _ Image Sources Dicom, JPEG and JPEG 2000 compliant SAME Target hardware PC compatible SAME Image Processing * Brightness! Contrast All processing tools Stack, Tools * Mouse button operation for quick Window/Level, Zoom, Pan, image manipulation*- Selectable Magnifying Glass, Probe, Spatial multiple image views Magnify, zoom Locator, Draw Shutter, Ruler, and pan- Flip (left/ right, top/bottom) Elliptical ROI, Rectangular ROI, and rotate- Image inversion Polygonal ROI, Text Area, Text Measurement and angles Callout, Protractor. Security SSL Encryption SAME 8. Performance: The results of nonclinical tests submitted showing Dicomt 3 compliance, along with bench testing (software validation and risk analysis) shows that this new device has equivalent indications and performs in an equivalent fashion to the named predicate. Therefore this device poses no new issues of safety or effectiveness, and is substantially equivalent to the predicate device.

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Documnent Control Roomn- W066-G609 Silver Spring, MD 20993-0002 Moksha Digital Software PVT Limited % Mr. Mark Job Responsible Third Party Official AUG 17-2010 Regulatory Technology Services LLC 1394 25 1hStreet NW BUFFALO MN 55313 Re: K102148 Trade/Device Name: CuriePACS (Dicomn PACS Software) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and Communications System Regulatory Class: II Product Code: LLZ Dated: July 29, 201 0 Received: July 30, 201 0 Dear Mr. Job: We have reviewed your Section 5 10(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the pro 'isions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into class LI (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concemning your device in the Federal Register. Please be advised that FDA's issuance of a substa~ntial equivalence determination does not mean that FDA has made a determination that your devic& complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and li'sting (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of

Page 2 medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your devide as described in your Section 5 10(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. if you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to prenmarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/medicaldevices/safety/reportaproblem/default~htmn for the CDRH's Office of Surveillance and Biometrics/Division of Postmark&t Surveillance. You nmay obtain other general information on your responsibilities uhder the Act from the Division of Small Manufacturers, International and Consumqr Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.g~ov/cdrh/industrv/sudport/index.html. Sincerely yours, Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure

Indications for Use 510(k) Number (if known): K102148. Device Name: CuriePACS (Dicomn PACS Software) Indications For Use: CuriePACS (Dicom PACS Software) Software is a software device that receives digital images and data from various sources (Computed Radiography, Magnetic Resonance Imaging, Ultrasound, Endoscopy, Computed Tomography, Digital X-Ray Mammography, Nuclear Medicine Imaging, Secondary Capture, Radio Fluoroscopy, X-Ray or other Angiograms such as CT Angic). Images and data can he captured, stored, communicated, processed and displayed within the system and or across computer networks at distributed locations. Lossy compressed mammographic images and digitized film screen images must not be reviewed for primary image interpretation. Mammographic images may only be interpreted using an FDA cleared monitor that offers at least 5 Megapixel resolution and meets other technical specifications reviewed and accepted by FDA. Prescription Use X AND/OR Over-The-Counter Use (Pant 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OlVD) Page I of I Division of Radiological Devices Office oflin vitro Diagnostic Device evaluation and Safety 610K